Researchers studied outcomes from 45,912 patients who received kidneys from 35,851 deceased coronavirus-positive donors between March 1, 2020, and March 30, 2023.
“The use of kidneys from donors with active or resolved COVID-19 is safe, with excellent outcomes during medium-term follow-up,” they wrote of their findings.
Notably, there was no increase in the rejection rate or transplanted organs either. With an average wait time for a kidney being between three and five years in the U.S., the study highlights that donors should not be excluded due to past or present COVID-19 infection and doing so would “substantially limit opportunities for organ use and [kidney transplant], which is not a benign consequence,” researchers wrote.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
